Clinical efficacy of different drug therapy combined with risperidone and cognitive-behavioral in the treatment of residual schizophrenia
-
摘要: 目的 研究分析2种不同药物联合利培酮及认知行为治疗残留型精神分裂症的临床疗效。 方法 选取2013年1月—2016年1月绍兴市第七人民医院精神科收治的残留型精神分裂症患者180例,治疗医师采用双盲方法将所有患者随机平分为2组,观察组行盐酸舍曲林片联合利培酮及认知行为治疗,对照组行氯氮平联合利培酮及认知行为治疗。对2组患者进行临床疗效评估,观察并记录2组患者精神分裂症认知功能成套测验(MCCB)、汉密尔顿抑郁量表(HAMD)、汉密尔顿焦虑量表(HAMA)、个人自尊量表(SES)、个体和社会功能量表(PSP)和自知力评估。 结果 2组患者治疗后1个月行临床疗效评估,观察组临床疗效有效率(93.33%)高于对照组(84.44%),差异具有统计学意义(P<0.05)。2组治疗后各项评分比较,观察组治疗后的汉密尔顿抑郁量表、汉密尔顿焦虑量表、自知力评估评分显著低于对照组治疗后,而观察组治疗后的个人自尊量表、个体和社会功能量表评分显著高于对照组治疗后,差异具有统计学意义(P<0.05)。 结论 盐酸曲舍林片联合利培酮及认知行为治疗可有效改善残留型精神分裂症患者的阴性症状、认知社会功能、提高生活质量,适合在临床广泛应用。Abstract: Objective To analyze the clinical efficacy of cognitive behavior research and analysis combined with risperidone in the treatment of residual schizophrenia. Methods One hundred and eighty cases of residual schizophrenia in psychiatric hospital from January,2013 to January,2016 were selected.The treating physician will use a double-blind method.All patients were randomly divided into two groups:Observation group underwent Hydrochloride tablets Schering joint risperidone and cognitive behavioral therapy;the control group underwent clozapine plus risperidone and cognitive behavioral therapy.Two groups of patients were assessed clinically efficacy.The two groups were observed and recorded Hamilton Depression Rating Scale, Anxiety Scale score,individual self-esteem scale score, individual and social function and insight Assessment Scale score. Results After treatment and 1 month to assess the efficacy of clinical observation group clinical efficacy rate (93.33%) was higher (84.44%),the difference was statistically significant (P<0.05).After treatment,the scores, the observation group after treatment Hamilton Depression Scale,Hamilton Anxiety Scale,insight assessment scores were significantly lower than those in the control group,while the observation group after treatment of personal self-esteem scale,individuals and Social Functioning scale scores were significantly higher than those after treatment,the differences were statistically significant (P<0.05). Conclusion Schering joint Hydrochloride tablets risperidone and cognitive behavioral therapy is effective in improving negative symptoms of patients with residual schizophrenia,cognitive social function, improve quality of life for clinicians widely used.
-
Key words:
- Residual schizophrenia /
- Hydrochloride Schering /
- Clozapine /
- Risperidone /
- Cognitive behavioral
点击查看大图
计量
- 文章访问数: 145
- HTML全文浏览量: 30
- PDF下载量: 0
- 被引次数: 0